ENTACOVER 1: Targeted Hepatitis B Treatment with Entecavir IP(1mg)

May 15, 2024

ENTACOVER 1

Entecavir IP(1mg)

ENTACOVER 1 is a leading antiviral medication designed specifically to combat hepatitis B virus (HBV) infection. Each tablet of ENTACOVER 1 contains 1mg of Entecavir, a potent antiviral agent known for its effectiveness in inhibiting viral replication. This medication is crucial for managing chronic hepatitis B, reducing the viral load, and limiting the progression of the disease to prevent long-term complications like cirrhosis and liver cancer.

Composition

ENTACOVER 1 contains:

  • Entecavir IP (1mg): A nucleoside analog that interferes with the viral DNA replication process, effectively reducing the ability of the hepatitis B virus to reproduce and spread.

Uses

ENTACOVER 1 is primarily used for:

  • Treatment of chronic hepatitis B infection in adults and children over the age of 2 years.
  • Reduction of viral replication in patients with active viral replication.
  • Improvement in liver function in patients with hepatitis B.

Dosage and Administration

ENTACOVER 1 is typically administered once daily on an empty stomach, at least 2 hours before or after a meal. The exact dosage and duration of treatment depend on the patient's condition, liver function, and viral load. Continuous monitoring by a healthcare provider is essential to adjust the dosage as needed and to monitor the response to therapy.

Side Effects

While ENTACOVER 1 is well tolerated by most patients, some may experience side effects such as:

  • Headache
  • Fatigue
  • Dizziness
  • Nausea
  • Elevated liver enzymes

Severe side effects include lactic acidosis and liver complications, which are rare but require immediate medical attention.

Price

The cost of ENTACOVER 1 can vary depending on the region and the healthcare system. It is typically available by prescription, and patients are advised to consult their healthcare provider for pricing information and potential insurance coverage.

Precautions

Patients with pre-existing liver conditions, renal impairment, or those on concurrent antiretrovirals should use ENTACOVER 1 with caution. Regular monitoring of liver function and viral load is recommended to assess the effectiveness of the treatment and to manage any emerging side effects.

Conclusion

ENTACOVER 1 represents a critical advancement in the management of hepatitis B, providing patients with a highly effective tool to control the viral load and improve liver health. As with any medication, adherence to prescribed guidelines and regular consultations with healthcare professionals are key to achieving the best outcomes. Patients considering ENTACOVER 1 should discuss its benefits and potential risks with their healthcare provider to ensure it is the appropriate choice for their treatment plan. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

SHARE WITH